Latest On PDL BioPharma, Inc (PDLI):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-12-14 23:34 EST | News | PDL BioPharma enters Capital Provision Agreement with Epps Investments | N/A |  |
| 2020-12-09 23:02 EST | News | PDL BioPharma indicates timeline for Nasdaq voluntarily delisting | N/A | |
| 2020-12-05 10:34 EST | News | PDL BioPharma Liquidation May Offer 40% Upside For Patient Investors Comfortable With Illiquidity | N/A | |
| 2020-11-26 21:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 05:03 EST | Earnings Estimate | An EPS average of $0.03 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-12 04:55 EST | Analyst Rating | The Analyst Target Price has decreased from $3 to $2.5. | Neutral | |
| 2020-11-12 02:42 EST | News | PDL BioPharma reports Q3 results | N/A | |
| 2020-11-12 02:41 EST | News | PDL BioPharma's (PDLI) CEO Dominique Monnet on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-08 00:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-03 05:24 EST | News | PDL BioPharma -16% PM on completion of LENSAR spin off | N/A | |
| 2020-10-01 18:00 EST | Insider Trade | PDL BIOPHARMA, INC. has directly acquired 8,703 shares and currently holds 8,667,397 shares. | Buy | |
| 2020-09-26 13:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-21 05:50 EST | Dividend | A dividend of $0.08 has been announced on Sep 10, 2020. It will be paid Oct 1, 2020 with an ex-dividend date of Sep 21, 2020. | Neutral | |
| 2020-09-17 05:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-10 03:19 EST | News | PDL Bio completes divestiture of the Noden Pharma to Stanley Capital | N/A | |
| 2020-08-29 08:17 EST | News | PDL BioPharma to buy ~$15M convertible notes in tender offer | N/A | |
| 2020-08-26 22:25 EST | News | PDL BioPharma advancing Lensar spinoff | N/A | |
| 2020-08-24 06:24 EST | Insider Trade | Elizabeth G. O'Farrell has directly acquired 25,826 shares and currently holds 89,117 shares. | Buy | |
| 2020-08-24 06:24 EST | Insider Trade | DAVID W GRYSKA has directly acquired 25,826 shares and currently holds 245,337 shares. | Buy | |
| 2020-08-24 06:24 EST | Insider Trade | Alan Lee Bazaar has directly acquired 25,826 shares and currently holds 33,435 shares. | Buy | |
| 2020-08-24 06:24 EST | Insider Trade | JOHN PETER MCLAUGHLIN has directly acquired 25,826 shares and currently holds 527,934 shares. | Buy | |
| 2020-08-24 06:24 EST | Insider Trade | Natasha Hernday has directly acquired 25,826 shares and currently holds 75,826 shares. | Buy | |
| 2020-08-14 09:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 22:54 EST | News | PDL BioPharma inks settlement agreement with Wellstat | N/A | |
| 2020-08-10 21:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-10 01:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-08 21:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-07 00:15 EST | News | PDL BioPharma EPS misses by $0.21, misses on revenue | N/A | |
| 2020-08-07 00:14 EST | News | PDL BioPharma, Inc. 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-08-07 00:14 EST | News | PDL BioPharma, Inc. (PDLI) CEO Dominique Monnet on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-06 13:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 17:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 05:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 13:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 18:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 09:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 17:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 13:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 05:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 05:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-02 05:36 EST | Earnings Estimate | An EPS average of $0.08 is estimated for the quarter ending on September 30, 2020. | Buy | |
| 2020-05-27 05:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-15 21:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-10 21:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-08 08:09 EST | News | PDL BioPharma EPS misses by $0.31, misses on revenue | N/A | |
| 2020-05-08 08:08 EST | News | PDL BioPharma's (PDLI) CEO Dominique Monnet on Q1 2020 Results - Earnings Call Transcript | N/A | |
| 2020-05-08 08:07 EST | News | PDL BioPharma, Inc. 2020 Q1 - Results - Earnings Call Presentation | N/A | |
| 2020-05-06 05:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 05:27 EST | Financials | Company financials have been released. | Neutral | |
About PDL BioPharma, Inc (PDLI):
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
General
- Name PDL BioPharma, Inc
- Symbol PDLI
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 109
- Last Split Factor2:1
- Last Split Date2001-10-10
- Fiscal Year EndDecember
- IPO Date1992-01-28
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.pdl.com
View More
Valuation
- Forward PE 64.94
- Price/Sales (Trailing 12 Mt.) 5.56
- Price/Book (Most Recent Quarter) 0.67
- Enterprise Value Revenue 3.67
- Enterprise Value EBITDA 6.97
View More
Financials
- Most Recent Quarter 2020-06-30
- Next Quarter EPS Estimate $0.08
- Operating Margin -167%
- Return on Assets -4%
- Return on Equity -7%
- Revenue 27.76 million
- Earnings Per Share $0.01
- Revenue Per Share $0.24
- Gross Profit 13.43 million
- Quarterly Earnings Growth -30.1%
View More
Highlights
- Market Capitalization 282.14 million
- EBITDA -4277000
- PEG Ratio 0.4
- Analyst Target Price $2.5
- Book Value Per Share $3.69
View More
Share Statistics
- Shares Outstanding 114.23 million
- Shares Float 77.67 million
- % Held by Insiders 227%
- % Held by Institutions 96.43%
- Shares Short 11.87 million
- Shares Short Prior Month 11.82 million
- Short Ratio 5.2
- Short % of Float 11%
- Short % of Shares Outstanding 10%
View More
Technicals
- Beta 1.14
- 52 Week High $3.86
- 52 Week Low $2.09
- 50 Day Moving Average 2.58
- 200 Day Moving Average 2.8
View More
Dividends
- Dividend Date 2016-06-13
- ExDividend Date 2016-06-02
- Dividend Yield 0%
View More
PDL BioPharma, Inc (PDLI) Dividend Calendar:
PDLI's last dividend payment was made to shareholders on June 13, 2016.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
PDL BioPharma, Inc (PDLI) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-11 | $0.04 | $0.06 | -33.33% | |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.43 | $0.10 | -530% |
| 2020-03-31 | 2020-05-07 | $6 million | -$0.26 | $0.05 | -620% |
| 2019-12-31 | 2020-03-11 | $20.97 million | -$0.48 | $0.05 | -1060% |
| 2019-09-30 | 2019-11-06 | $20.3 million | -$0.16 | $0.05 | -420% |
| 2019-06-30 | 2019-08-07 | $17.87 million | -$0.04 | $0.04 | -200% |
| 2019-03-31 | 2019-05-09 | $26.66 million | $0.05 | $0.08 | -37.5% |
| 2018-12-31 | 2019-03-14 | $25.9 million | $0.11 | $0.08 | 37.5% |
| 2018-09-30 | 2018-11-06 | $24.96 million | $0.18 | $0.07 | 157.14% |
| 2018-06-30 | 2018-08-08 | $32.98 million | -$0.76 | $0.06 | -1366.67% |
| 2018-03-31 | 2018-05-09 | $38.52 million | $0.01 | $0.09 | -88.89% |
| 2017-12-31 | 2018-03-08 | $68.04 million | $0.15 | $0.03 | 400% |
| 2017-09-30 | 2017-11-02 | $62.75 million | $0.14 | $0.13 | 7.69% |
| 2017-06-30 | 2017-08-03 | $143.84 million | $0.39 | $0.09 | 333.33% |
| 2017-03-31 | 2017-05-03 | $45.44 million | $0.04 | $0.05 | -20% |
| 2016-12-31 | 2017-03-01 | $66.49 million | -$0.06 | $0.09 | -164.31% |
| 2016-09-30 | 2016-11-03 | $53.64 million | $0.08 | $0.08 | 0% |
| 2016-06-30 | 2016-08-04 | $21.05 million | $0.03 | $0.08 | -62.5% |
| 2016-03-31 | 2016-05-04 | $103.12 million | $0.34 | $0.50 | -32% |
| 2015-12-31 | 2016-02-22 | $178.06 million | $0.61 | $0.54 | 12.96% |
| 2015-09-30 | 2015-11-04 | $119.8 million | $0.42 | $0.61 | -31.15% |
| 2015-06-30 | 2015-08-05 | $138.07 million | $0.47 | $0.52 | -9.62% |
| 2015-03-31 | 2015-05-06 | $149.71 million | $0.50 | $0.52 | -3.85% |
| 2014-12-31 | 2015-02-23 | $114.22 million | $0.32 | $0.56 | -42.86% |
| 2014-09-30 | 2014-11-10 | $164.59 million | $0.61 | $0.55 | 10.91% |
| 2014-06-30 | 2014-08-18 | $162.75 million | $0.52 | $0.46 | 13.04% |
| 2014-03-31 | 2014-05-12 | $139.66 million | $0.42 | $0.45 | -6.67% |
| 2013-12-31 | 2014-03-03 | $110.14 million | $0.41 | $0.43 | -4.65% |
| 2013-09-30 | 2013-11-06 | $97.31 million | $0.36 | $0.37 | -2.7% |
| 2013-06-30 | 2013-08-08 | $143.62 million | $0.62 | $0.53 | 16.98% |
| 2013-03-31 | 2013-05-09 | $91.85 million | $0.36 | $0.35 | 2.86% |
| 2012-12-31 | 2013-03-01 | $86.05 million | $0.34 | $0.32 | 6.25% |
| 2012-09-30 | 2012-11-05 | $85.23 million | $0.32 | $0.30 | 6.67% |
| 2012-06-30 | 2012-08-02 | $125.9 million | $0.52 | $0.49 | 6.12% |
| 2012-03-31 | 2012-05-03 | $77.34 million | $0.30 | $0.26 | 15.38% |
| 2011-12-31 | 2012-02-23 | $72.81 million | $0.24 | $0.24 | 0% |
| 2011-09-30 | 2011-11-09 | $83.77 million | $0.28 | $0.27 | 3.7% |
| 2011-06-30 | 2011-07-27 | $122.13 million | $0.39 | $0.40 | -2.5% |
| 2011-03-31 | 2011-04-27 | $83.34 million | $0.25 | $0.24 | 4.17% |
| 2010-12-31 | 2011-02-28 | $76.13 million | $0.20 | $0.21 | -4.76% |
| 2010-09-30 | 2010-11-10 | $86.44 million | $0.24 | $0.25 | -4% |
| 2010-06-30 | 2010-07-28 | $120.34 million | $0.30 | $0.38 | -21.05% |
| 2010-03-31 | 2010-04-29 | $62.06 million | $0.15 | $0.23 | -34.78% |
| 2009-12-31 | 2010-03-01 | $58.25 million | $0.17 | $0.19 | -10.53% |
| 2009-09-30 | 2009-10-28 | $71.45 million | $0.29 | $0.26 | 11.54% |
| 2009-06-30 | 2009-07-30 | $125.86 million | $0.47 | $0.43 | 9.3% |
| 2009-03-31 | 2009-05-07 | $62.62 million | $0.23 | $0.24 | -4.17% |
| 2008-12-31 | 2009-03-02 | $68.66 million | $0.34 | $0.08 | 325% |
| 2008-09-30 | 2008-11-06 | $68.82 million | $0.08 | $0.18 | -55.56% |
| 2008-06-30 | 2008-08-11 | $106.53 million | $0.35 | $0.20 | 75% |
| 2008-03-31 | 2008-05-08 | $50.19 million | $0.23 | $0.08 | 187.5% |
| 2007-12-31 | 2008-03-04 | $49.76 million | $0.04 | $0.11 | -63.64% |
| 2007-09-30 | 2007-11-08 | $61.26 million | $0.16 | $0.13 | 23.08% |
| 2007-06-30 | 2007-08-01 | $89.06 million | $0.30 | $0.27 | 11.11% |
| 2007-03-31 | 2007-05-02 | $58.86 million | $0.09 | $0.12 | -25% |
| 2006-12-31 | 2007-02-21 | $107.84 million | $0.05 | $0.08 | -37.5% |
| 2006-09-30 | 2006-11-02 | $111.39 million | $0.23 | ||
| 2006-06-30 | 2006-08-03 | $104.32 million | $0.17 | $0.10 | 70% |
| 2006-03-31 | 2006-05-02 | $91.21 million | $0.02 | $0.14 | -85.71% |
| 2005-12-31 | 2006-02-27 | $83.65 million | $0.06 | $0.05 | 20% |
| 2005-09-30 | 2005-11-01 | $77.13 million | -$0.11 | -$0.03 | -266.67% |
| 2005-06-30 | 2005-08-04 | $80.97 million | $0.09 | $0.05 | 80% |
| 2005-03-31 | 2005-05-02 | $38.82 million | -$0.03 | -$0.11 | 72.73% |
| 2004-12-31 | 2005-03-14 | $22.83 million | -$0.14 | -$0.15 | 6.67% |
| 2004-09-30 | 2004-11-01 | $19.78 million | -$0.13 | -$0.21 | 38.1% |
| 2004-06-30 | 2004-08-03 | $25.78 million | -$0.12 | -$0.12 | 0% |
| 2004-03-31 | 2004-05-04 | $27.63 million | -$0.13 | -$0.11 | -18.18% |
| 2003-12-31 | 2004-02-26 | $13.61 million | -$0.19 | -$0.22 | 13.64% |
| 2003-09-30 | 2003-11-03 | $9.33 million | -$0.20 | -$0.21 | 4.76% |
| 2003-06-30 | 2003-07-29 | $21 million | -$0.05 | -$0.06 | 16.67% |
| 2003-03-31 | 2003-04-29 | $22.75 million | $0.05 | -$0.02 | 350% |
| 2002-12-31 | 2003-02-26 | $10.71 million | -$0.09 | -$0.09 | 0% |
| 2002-09-30 | 2002-11-07 | $6.54 million | -$0.09 | -$0.10 | 10% |
| 2002-06-30 | 2002-08-07 | $14.79 million | -$0.01 | ||
| 2002-03-31 | 2002-05-09 | $14.33 million | $0.02 | $0.01 | 100% |
| 2001-12-31 | 2002-02-28 | $6.93 million | -$0.06 | -$0.05 | -20% |
| 2001-09-30 | 2001-11-01 | $8.06 million | -$0.02 | -$0.05 | 60% |
| 2001-06-30 | 2001-08-02 | $12.68 million | $0.04 | $0.03 | 33.33% |
| 2001-03-31 | 2001-05-14 | $16.73 million | $0.07 | $0.04 | 75% |
| 2000-12-31 | 2001-02-13 | $6.86 million | $-0.00 | -$0.04 | 98.5% |
| 2000-09-30 | 2000-11-08 | $4.7 million | -$0.06 | -$0.08 | 25% |
| 2000-06-30 | 2000-08-01 | $15.89 million | $0.06 | $0.06 | 0% |
| 2000-03-31 | 2000-04-17 | $12.45 million | $0.01 | -$0.01 | 200% |
| 1999-12-31 | 2000-02-28 | -$0.08 | -$0.08 | 0% | |
| 1999-09-30 | 1999-11-03 | $0.00 | -$0.06 | 103.83% | |
| 1999-06-30 | 1999-08-04 | -$0.04 | -$0.02 | -100% | |
| 1999-03-31 | 1999-05-06 | -$0.02 | -$0.04 | 50% | |
| 1998-12-31 | 1999-02-22 | -$0.07 | -$0.06 | -16.67% | |
| 1998-09-30 | 1998-10-26 | $0.01 | -$0.05 | 120% | |
| 1998-06-30 | 1998-08-05 | -$0.01 | -$0.06 | 83.33% | |
| 1998-03-31 | 1998-05-07 | -$0.05 | -$0.06 | 16.67% | |
| 1997-12-31 | 1998-02-11 | -$0.06 | -$0.06 | 0% | |
| 1997-09-30 | 1997-11-14 | -$0.01 | -$0.05 | 80% | |
| 1997-06-30 | 1997-08-12 | -$0.04 | -$0.06 | 33.33% | |
| 1997-03-31 | 1997-05-06 | -$0.06 | -$0.07 | 14.29% | |
| 1996-12-31 | 1997-02-03 | -$0.03 | -$0.07 | 57.14% | |
| 1996-09-30 | 1996-10-17 | -$0.05 | -$0.05 | 0% | |
| 1996-06-30 | 1996-08-13 | -$0.05 | -$0.05 | 0% | |
| 1996-03-31 | 1996-05-06 | -$0.04 | -$0.05 | 20% | |
| 1995-12-31 | 1996-02-08 | -$0.03 | -$0.05 | 40% |
PDL BioPharma, Inc (PDLI) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
PDL BioPharma, Inc (PDLI) Chart:
PDL BioPharma, Inc (PDLI) News:
Below you will find a list of latest news for PDL BioPharma, Inc (PDLI) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
PDL BioPharma, Inc (PDLI) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
PDL BioPharma, Inc (PDLI) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/882104/000088210420000096/0000882104-20-000096-index.htm |
| 2019-06-06 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/882104/000000000019009527/0000000000-19-009527-index.htm |
| 2020-05-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/882104/000000000020004492/0000000000-20-004492-index.htm |
| 2020-06-19 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/882104/000000000020005482/0000000000-20-005482-index.htm |
| 2020-07-02 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/882104/000000000020005964/0000000000-20-005964-index.htm |
| 2020-07-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/882104/000000000020006120/0000000000-20-006120-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000009375119000111/0000093751-19-000111-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000021545719004975/0000215457-19-004975-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000083423720005956/0000834237-20-005956-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210418000103/0000882104-18-000103-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210418000104/0000882104-18-000104-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210418000105/0000882104-18-000105-index.htm |
| 2018-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210418000107/0000882104-18-000107-index.htm |
| 2018-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210418000109/0000882104-18-000109-index.htm |
| 2018-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210418000111/0000882104-18-000111-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210418000114/0000882104-18-000114-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882104/000088210418000117/0000882104-18-000117-index.htm |
| 2018-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210418000119/0000882104-18-000119-index.htm |
| 2018-11-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210418000121/0000882104-18-000121-index.htm |
| 2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210418000123/0000882104-18-000123-index.htm |
| 2018-12-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210418000128/0000882104-18-000128-index.htm |
| 2018-12-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210418000129/0000882104-18-000129-index.htm |
| 2018-12-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210418000130/0000882104-18-000130-index.htm |
| 2018-12-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210418000131/0000882104-18-000131-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000002/0000882104-19-000002-index.htm |
| 2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000004/0000882104-19-000004-index.htm |
| 2019-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000007/0000882104-19-000007-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000009/0000882104-19-000009-index.htm |
| 2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000015/0000882104-19-000015-index.htm |
| 2019-03-15 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882104/000088210419000016/0000882104-19-000016-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000018/0000882104-19-000018-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000023/0000882104-19-000023-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000024/0000882104-19-000024-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000025/0000882104-19-000025-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000026/0000882104-19-000026-index.htm |
| 2019-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000028/0000882104-19-000028-index.htm |
| 2019-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000030/0000882104-19-000030-index.htm |
| 2019-04-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000031/0000882104-19-000031-index.htm |
| 2019-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000033/0000882104-19-000033-index.htm |
| 2019-04-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000038/0000882104-19-000038-index.htm |
| 2019-04-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000039/0000882104-19-000039-index.htm |
| 2019-04-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000040/0000882104-19-000040-index.htm |
| 2019-04-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000041/0000882104-19-000041-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/882104/000088210419000044/0000882104-19-000044-index.htm |
| 2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882104/000088210419000046/0000882104-19-000046-index.htm |
| 2019-05-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882104/000088210419000048/0000882104-19-000048-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000053/0000882104-19-000053-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882104/000088210419000054/0000882104-19-000054-index.htm |
| 2019-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000056/0000882104-19-000056-index.htm |
| 2019-05-31 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/882104/000088210419000059/0000882104-19-000059-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000061/0000882104-19-000061-index.htm |
| 2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000063/0000882104-19-000063-index.htm |
| 2019-06-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000065/0000882104-19-000065-index.htm |
| 2019-06-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000067/0000882104-19-000067-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000069/0000882104-19-000069-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000070/0000882104-19-000070-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000071/0000882104-19-000071-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000072/0000882104-19-000072-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000073/0000882104-19-000073-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000074/0000882104-19-000074-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000075/0000882104-19-000075-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000077/0000882104-19-000077-index.htm |
| 2019-06-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/882104/000088210419000079/0000882104-19-000079-index.htm |
| 2019-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210419000082/0000882104-19-000082-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000087/0000882104-19-000087-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882104/000088210419000089/0000882104-19-000089-index.htm |
| 2019-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000093/0000882104-19-000093-index.htm |
| 2019-08-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000095/0000882104-19-000095-index.htm |
| 2019-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000097/0000882104-19-000097-index.htm |
| 2019-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000099/0000882104-19-000099-index.htm |
| 2019-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000101/0000882104-19-000101-index.htm |
| 2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000103/0000882104-19-000103-index.htm |
| 2019-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000105/0000882104-19-000105-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000110/0000882104-19-000110-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882104/000088210419000111/0000882104-19-000111-index.htm |
| 2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000114/0000882104-19-000114-index.htm |
| 2019-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000116/0000882104-19-000116-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000118/0000882104-19-000118-index.htm |
| 2019-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000120/0000882104-19-000120-index.htm |
| 2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000122/0000882104-19-000122-index.htm |
| 2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000124/0000882104-19-000124-index.htm |
| 2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210419000126/0000882104-19-000126-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000005/0000882104-20-000005-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000006/0000882104-20-000006-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000007/0000882104-20-000007-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000008/0000882104-20-000008-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000010/0000882104-20-000010-index.htm |
| 2020-01-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882104/000088210420000013/0000882104-20-000013-index.htm |
| 2020-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000017/0000882104-20-000017-index.htm |
| 2020-02-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882104/000088210420000018/0000882104-20-000018-index.htm |
| 2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000020/0000882104-20-000020-index.htm |
| 2020-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000031/0000882104-20-000031-index.htm |
| 2020-03-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882104/000088210420000032/0000882104-20-000032-index.htm |
| 2020-03-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882104/000088210420000034/0000882104-20-000034-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000042/0000882104-20-000042-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000043/0000882104-20-000043-index.htm |
| 2020-04-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000044/0000882104-20-000044-index.htm |
| 2020-04-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000045/0000882104-20-000045-index.htm |
| 2020-04-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000046/0000882104-20-000046-index.htm |
| 2020-04-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000047/0000882104-20-000047-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000048/0000882104-20-000048-index.htm |
| 2020-04-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000051/0000882104-20-000051-index.htm |
| 2020-04-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000052/0000882104-20-000052-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000055/0000882104-20-000055-index.htm |
| 2020-05-05 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/882104/000088210420000057/0000882104-20-000057-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000060/0000882104-20-000060-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000064/0000882104-20-000064-index.htm |
| 2020-05-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882104/000088210420000067/0000882104-20-000067-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882104/000088210420000071/0000882104-20-000071-index.htm |
| 2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000073/0000882104-20-000073-index.htm |
| 2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000075/0000882104-20-000075-index.htm |
| 2020-06-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/882104/000088210420000079/0000882104-20-000079-index.htm |
| 2020-06-05 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/882104/000088210420000081/0000882104-20-000081-index.htm |
| 2020-06-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000083/0000882104-20-000083-index.htm |
| 2020-06-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/882104/000088210420000085/0000882104-20-000085-index.htm |
| 2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000094/0000882104-20-000094-index.htm |
| 2020-06-30 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/882104/000088210420000096/0000882104-20-000096-index.htm |
| 2020-07-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/882104/000088210420000098/0000882104-20-000098-index.htm |
| 2020-07-07 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/882104/000088210420000100/0000882104-20-000100-index.htm |
| 2020-07-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000102/0000882104-20-000102-index.htm |
| 2020-07-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000104/0000882104-20-000104-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000106/0000882104-20-000106-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000112/0000882104-20-000112-index.htm |
| 2020-08-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882104/000088210420000113/0000882104-20-000113-index.htm |
| 2020-08-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882104/000088210420000114/0000882104-20-000114-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882104/000088210420000120/0000882104-20-000120-index.htm |
| 2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000123/0000882104-20-000123-index.htm |
| 2020-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000126/0000882104-20-000126-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000132/0000882104-20-000132-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000133/0000882104-20-000133-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000134/0000882104-20-000134-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000135/0000882104-20-000135-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000088210420000136/0000882104-20-000136-index.htm |
| 2020-08-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000139/0000882104-20-000139-index.htm |
| 2020-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000142/0000882104-20-000142-index.htm |
| 2020-08-28 | SC TO-I | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/882104/000088210420000144/0000882104-20-000144-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000146/0000882104-20-000146-index.htm |
| 2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000150/0000882104-20-000150-index.htm |
| 2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000154/0000882104-20-000154-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000156/0000882104-20-000156-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000158/0000882104-20-000158-index.htm |
| 2020-09-15 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/882104/000088210420000161/0000882104-20-000161-index.htm |
| 2020-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000166/0000882104-20-000166-index.htm |
| 2020-10-05 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/882104/000088210420000168/0000882104-20-000168-index.htm |
| 2020-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882104/000088210420000173/0000882104-20-000173-index.htm |
| 2019-04-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000089924319010887/0000899243-19-010887-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000089924319016240/0000899243-19-016240-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000089924320014185/0000899243-20-014185-index.htm |
| 2020-09-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000089924320025566/0000899243-20-025566-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882104/000089924320026691/0000899243-20-026691-index.htm |
| 2020-08-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000090571820000913/0000905718-20-000913-index.htm |
| 2020-08-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000090571820000915/0000905718-20-000915-index.htm |
| 2019-10-23 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/882104/000092189519002588/0000921895-19-002588-index.htm |
| 2020-02-28 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/882104/000092189520000614/0000921895-20-000614-index.htm |
| 2020-03-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/882104/000092189520000701/0000921895-20-000701-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000093247119005747/0000932471-19-005747-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000103738919000218/0001037389-19-000218-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000103738920000240/0001037389-20-000240-index.htm |
| 2020-01-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000110465920002640/0001104659-20-002640-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000110465920018905/0001104659-20-018905-index.htm |
| 2020-04-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882104/000110465920053337/0001104659-20-053337-index.htm |
| 2019-04-18 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/882104/000119312519110809/0001193125-19-110809-index.htm |
| 2019-06-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/882104/000119312519169440/0001193125-19-169440-index.htm |
| 2019-08-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/882104/000119312519219124/0001193125-19-219124-index.htm |
| 2019-10-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/882104/000119312519266736/0001193125-19-266736-index.htm |
| 2020-05-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/882104/000119312520151580/0001193125-20-151580-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000125889719001249/0001258897-19-001249-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882104/000125889720001227/0001258897-20-001227-index.htm |
| 2019-06-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/882104/999999999519001463/9999999995-19-001463-index.htm |
PDL BioPharma, Inc (PDLI) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PDL BioPharma, Inc (PDLI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 227%Institutional Ownership: 9643%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-06-10 | PDL BIOPHARMA, INC. | 10% Share Holder | Buy | 6,666,667.00 | 4.50 | 30,000,001.50 | 13,333,334.00 | https://www.sec.gov/Archives/edgar/data/882104/000089924319016240/0000899243-19-016240-index.htm |
| 2020-01-08 | Dominique Monnet | President and CEO | Buy | 1,233,766.00 | 1,907,426.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000006/0000882104-20-000006-index.htm | ||
| 2020-01-08 | Jill M. Jene | VP, Business Development | Buy | 194,805.00 | 194,805.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000005/0000882104-20-000005-index.htm | ||
| 2018-12-27 | Christopher Lewis Stone | VP, Gen. Counsel & Secretary | Sell | 228,255.00 | 198,951.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210418000129/0000882104-18-000129-index.htm | ||
| 2018-12-27 | PETER S GARCIA | Vice President, CFO | Sell | 226,442.00 | 225,029.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210418000130/0000882104-18-000130-index.htm | ||
| 2020-08-19 | DAVID W GRYSKA | Director | Buy | 25,826.00 | 245,337.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000132/0000882104-20-000132-index.htm | ||
| 2020-01-08 | Edward Imbrogno | VP Finance, CAO and Acting CFO | Buy | 292,208.00 | 314,565.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000008/0000882104-20-000008-index.htm | ||
| 2020-08-19 | Alan Lee Bazaar | Director | Buy | 25,826.00 | 33,435.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000133/0000882104-20-000133-index.htm | ||
| 2019-06-20 | Natasha Hernday | Director | Buy | 50,000.00 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210419000074/0000882104-19-000074-index.htm | ||
| 2018-12-31 | JOHN PETER MCLAUGHLIN | CEO | Sell | 123,449.00 | 502,108.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210419000004/0000882104-19-000004-index.htm | ||
| 2020-08-19 | JOHN PETER MCLAUGHLIN | Director | Buy | 25,826.00 | 527,934.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000134/0000882104-20-000134-index.htm | ||
| 2020-01-08 | Christopher Lewis Stone | VP, Gen. Counsel & Secretary | Buy | 422,078.00 | 621,029.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000007/0000882104-20-000007-index.htm | ||
| 2018-12-27 | JOHN PETER MCLAUGHLIN | CEO | Sell | 627,228.00 | 625,557.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210418000128/0000882104-18-000128-index.htm | ||
| 2019-03-28 | Dominique Monnet | President and CEO | Buy | 431,317.00 | 3.72 | 1,604,499.24 | 653,902.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210419000024/0000882104-19-000024-index.htm |
| 2020-08-19 | Natasha Hernday | Director | Buy | 25,826.00 | 75,826.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000135/0000882104-20-000135-index.htm | ||
| 2020-04-17 | Alan Lee Bazaar | Director | Buy | 7,609.00 | 7,609.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000052/0000882104-20-000052-index.htm | ||
| 2020-09-29 | PDL BIOPHARMA, INC. | 10% Share Holder | Buy | 8,703.00 | 11.16 | 97,125.48 | 8,667,397.00 | https://www.sec.gov/Archives/edgar/data/882104/000089924320026691/0000899243-20-026691-index.htm |
| 2020-08-19 | Elizabeth G. O'Farrell | Director | Buy | 25,826.00 | 89,117.00 | https://www.sec.gov/Archives/edgar/data/882104/000088210420000136/0000882104-20-000136-index.htm |